Key result
Arrhythmogenic right ventricular cardiomyopathy was not associated with a significant decrease in plakoglobin expression compared to controls (4.6% vs 4.9%, p=0.3), suggesting immunohistochemistry is not a useful diagnostic tool.
Why the study?
Does quantitative immunohistochemical staining for desmosomal proteins differentiate autopsy-confirmed arrhythmogenic right ventricular cardiomyopathy from control hearts?
Case-Control (n=44)
Single-blind
Does quantitative immunohistochemical staining for desmosomal proteins differentiate autopsy-confirmed arrhythmogenic right ventricular cardiomyopathy from control hearts?
Quantitative immunohistochemistry of desmosomal proteins does not reliably distinguish arrhythmogenic right ventricular cardiomyopathy from normal or other diseased hearts, challenging its utility as a diagnostic tool.
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder related to mutations in desmosomal proteins. The current study tests the hypothesis that immunohistochemical staining for desmosomal proteins is of diagnostic utility by studying autopsy-confirmed cases of ARVC. METHODS AND RESULTS: We studied 23 hearts from patients dying suddenly with ARVC. Control subject tissues were 21 hearts from people dying from non-cardiac causes (n=15), dilated cardiomyopathy (n=3) and coronary artery disease (n=3). Areas free of fibrofatty change or scarring were assessed on 50 sections from ARVC (24 left ventricle, 26 right ventricle) and 28 sections from controls. Immunohistochemical stains against plakoglobin, plakophilin, desmoplakin, connexin-43, and N-cadherin were applied and area expression analyzed by computerized morphometry. Desmin was stained as a control for fixation and similarly analyzed. The mean area of desmin expression was similar in controls and ARVC (86% vs. 85%, p=0.6). Plakoglobin expression was 4.9% ± 0.3% in controls, vs. 4.6% ± 0.3% in ARVC (p=0.3). Plakophilin staining was 4.8% ± 0.3% in controls vs. 4.4% ± 03% in ARVC (p=0.3). Desmoplakin staining was 3.4% in controls vs. 3.2 ± 0.2% in ARVC (p=0.6). There were no significant differences when staining was compared between right and left ventricles (all p > 0.1). For non-desmosomal proteins, the mean area of connexin-43 staining showed no significant difference by presence of disease. CONCLUSIONS: The small and insignificant decrease in junction protein expression in ARVC suggests that immunohistochemistry is not a useful tool for the diagnosis.
No takes yet. Share an insight, caveat, or question.
Tavora et al. (2013) conducted a case-control in Arrhythmogenic Right Ventricular Cardiomyopathy (n=44). Arrhythmogenic Right Ventricular Cardiomyopathy vs. Control subjects without ARVC was evaluated on Plakoglobin expression area (p=0.3). Arrhythmogenic right ventricular cardiomyopathy was not associated with a significant decrease in plakoglobin expression compared to controls (4.6% vs 4.9%, p=0.3), suggesting immunohistochemistry is not a useful diagnostic tool.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: